3-iodobenzylguanidine has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hellström, PM; Jacobsson, H; Jonas, E; Larsson, SA | 1 |
| Aburano, T; Bunko, H; Hisada, K | 1 |
1 review(s) available for 3-iodobenzylguanidine and Liver Dysfunction
| Article | Year |
|---|---|
[New horizons for in vivo nuclear medicine in 1980s].
Topics: 3-Iodobenzylguanidine; Amphetamines; Biliary Tract Diseases; Brain Diseases; Coronary Disease; Gastrointestinal Diseases; Humans; Imino Acids; Iodobenzenes; Iofetamine; Krypton; Liver Diseases; Lung Diseases; Neoplasms; Radionuclide Imaging; Technetium; Technetium Tc 99m Lidofenin; Thallium; Tomography, Emission-Computed | 1985 |
1 other study(ies) available for 3-iodobenzylguanidine and Liver Dysfunction
| Article | Year |
|---|---|
Different concentrations of various radiopharmaceuticals in the two main liver lobes: a preliminary study in clinical patients.
Topics: 3-Iodobenzylguanidine; Adult; Age Factors; Case-Control Studies; Dose-Response Relationship, Drug; Female; Humans; Liver Diseases; Male; Middle Aged; Probability; Radiopharmaceuticals; Reference Values; Retrospective Studies; Sensitivity and Specificity; Sex Factors; Time Factors; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2005 |